
Raymond J. Henley Iii
Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1205, 2899, 1629, 1614, 1621 |
| Total Applications | 4324 |
| Issued Applications | 3034 |
| Pending Applications | 603 |
| Abandoned Applications | 710 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4406543
[patent_doc_number] => 06271228
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Blood pressure stabilization during hemodialysis'
[patent_app_type] => 1
[patent_app_number] => 9/800836
[patent_app_country] => US
[patent_app_date] => 2001-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5336
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/271/06271228.pdf
[firstpage_image] =>[orig_patent_app_number] => 800836
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/800836 | Blood pressure stabilization during hemodialysis | Mar 6, 2001 | Issued |
Array
(
[id] => 1342558
[patent_doc_number] => 06586413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-01
[patent_title] => 'Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists'
[patent_app_type] => B2
[patent_app_number] => 09/800274
[patent_app_country] => US
[patent_app_date] => 2001-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 48
[patent_no_of_words] => 14830
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586413.pdf
[firstpage_image] =>[orig_patent_app_number] => 09800274
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/800274 | Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists | Mar 4, 2001 | Issued |
Array
(
[id] => 6934728
[patent_doc_number] => 20010056072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-27
[patent_title] => 'Compounds and their uses'
[patent_app_type] => new
[patent_app_number] => 09/798124
[patent_app_country] => US
[patent_app_date] => 2001-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11627
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20010056072.pdf
[firstpage_image] =>[orig_patent_app_number] => 09798124
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/798124 | Compounds and their uses | Mar 1, 2001 | Issued |
Array
(
[id] => 1396144
[patent_doc_number] => 06545145
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-08
[patent_title] => 'Purified Alteromonas macleodii polysaccharide and its uses'
[patent_app_type] => B1
[patent_app_number] => 09/720238
[patent_app_country] => US
[patent_app_date] => 2001-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2947
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/545/06545145.pdf
[firstpage_image] =>[orig_patent_app_number] => 09720238
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/720238 | Purified Alteromonas macleodii polysaccharide and its uses | Mar 1, 2001 | Issued |
Array
(
[id] => 7079066
[patent_doc_number] => 20010041695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-15
[patent_title] => 'Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals'
[patent_app_type] => new
[patent_app_number] => 09/797305
[patent_app_country] => US
[patent_app_date] => 2001-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5117
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20010041695.pdf
[firstpage_image] =>[orig_patent_app_number] => 09797305
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/797305 | Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals | Feb 28, 2001 | Issued |
| 09/719858 | Use of a pyridazinone derivative | Feb 27, 2001 | Abandoned |
Array
(
[id] => 7402015
[patent_doc_number] => 20040019080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Prevention and treatment of migraine and other recurrent headaches using leukotriene LTD4 receptor blocker drugs'
[patent_app_type] => new
[patent_app_number] => 09/794457
[patent_app_country] => US
[patent_app_date] => 2001-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15324
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20040019080.pdf
[firstpage_image] =>[orig_patent_app_number] => 09794457
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/794457 | Prevention and treatment of migraine and other recurrent headaches using leukotriene LTD4 receptor blocker drugs | Feb 26, 2001 | Abandoned |
Array
(
[id] => 6291610
[patent_doc_number] => 20020055490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => 'Medicament'
[patent_app_type] => new
[patent_app_number] => 09/794723
[patent_app_country] => US
[patent_app_date] => 2001-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11764
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20020055490.pdf
[firstpage_image] =>[orig_patent_app_number] => 09794723
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/794723 | Medicament | Feb 26, 2001 | Abandoned |
Array
(
[id] => 1550157
[patent_doc_number] => 06346544
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-02-12
[patent_title] => 'Desmethyl tocopherols for protecting cardiovascular tissue'
[patent_app_type] => B2
[patent_app_number] => 09/794292
[patent_app_country] => US
[patent_app_date] => 2001-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 7884
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/346/06346544.pdf
[firstpage_image] =>[orig_patent_app_number] => 09794292
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/794292 | Desmethyl tocopherols for protecting cardiovascular tissue | Feb 26, 2001 | Issued |
Array
(
[id] => 1380367
[patent_doc_number] => 06555519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-29
[patent_title] => 'O-glucosylated benzamide SGLT2 inhibitors and method'
[patent_app_type] => B2
[patent_app_number] => 09/791186
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11136
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 351
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555519.pdf
[firstpage_image] =>[orig_patent_app_number] => 09791186
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/791186 | O-glucosylated benzamide SGLT2 inhibitors and method | Feb 22, 2001 | Issued |
Array
(
[id] => 4371775
[patent_doc_number] => 06288118
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Therapies for treating pulmonary diseases'
[patent_app_type] => 1
[patent_app_number] => 9/763516
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2136
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288118.pdf
[firstpage_image] =>[orig_patent_app_number] => 763516
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/763516 | Therapies for treating pulmonary diseases | Feb 22, 2001 | Issued |
Array
(
[id] => 4410391
[patent_doc_number] => 06300377
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Coenzyme Q products exhibiting high dissolution qualities'
[patent_app_type] => 1
[patent_app_number] => 9/790783
[patent_app_country] => US
[patent_app_date] => 2001-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6460
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300377.pdf
[firstpage_image] =>[orig_patent_app_number] => 790783
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/790783 | Coenzyme Q products exhibiting high dissolution qualities | Feb 21, 2001 | Issued |
Array
(
[id] => 1073802
[patent_doc_number] => 06838467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-04
[patent_title] => 'Dosing regimen'
[patent_app_type] => utility
[patent_app_number] => 10/220162
[patent_app_country] => US
[patent_app_date] => 2001-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12389
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 239
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838467.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220162
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220162 | Dosing regimen | Feb 19, 2001 | Issued |
Array
(
[id] => 6898831
[patent_doc_number] => 20010046996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-29
[patent_title] => 'Use of a compound for preparing a drug'
[patent_app_type] => new
[patent_app_number] => 09/784302
[patent_app_country] => US
[patent_app_date] => 2001-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1608
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20010046996.pdf
[firstpage_image] =>[orig_patent_app_number] => 09784302
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/784302 | Method for the treatment of Multiple Sclerosis | Feb 15, 2001 | Issued |
Array
(
[id] => 4352837
[patent_doc_number] => 06291462
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates'
[patent_app_type] => 1
[patent_app_number] => 9/700055
[patent_app_country] => US
[patent_app_date] => 2001-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4162
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291462.pdf
[firstpage_image] =>[orig_patent_app_number] => 700055
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/700055 | Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates | Feb 15, 2001 | Issued |
Array
(
[id] => 6885091
[patent_doc_number] => 20010039255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-08
[patent_title] => 'Use of alpha1A adrenoceptor agonists with alpha1B and alpha1D antagonism for the treatment of stress urinary incontinence'
[patent_app_type] => new
[patent_app_number] => 09/788198
[patent_app_country] => US
[patent_app_date] => 2001-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4235
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20010039255.pdf
[firstpage_image] =>[orig_patent_app_number] => 09788198
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/788198 | Use of .alpha.1A adrenoceptor agonists with .alpha.1B and .alpha.1D antagonism for the treatment of stress urinary incontinence | Feb 15, 2001 | Issued |
Array
(
[id] => 1493522
[patent_doc_number] => 06403121
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-11
[patent_title] => 'Core formulation'
[patent_app_type] => B1
[patent_app_number] => 09/783783
[patent_app_country] => US
[patent_app_date] => 2001-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4066
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/403/06403121.pdf
[firstpage_image] =>[orig_patent_app_number] => 09783783
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/783783 | Core formulation | Feb 14, 2001 | Issued |
Array
(
[id] => 6898835
[patent_doc_number] => 20010047000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-29
[patent_title] => 'Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure'
[patent_app_type] => new
[patent_app_number] => 09/784559
[patent_app_country] => US
[patent_app_date] => 2001-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10092
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20010047000.pdf
[firstpage_image] =>[orig_patent_app_number] => 09784559
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/784559 | Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure | Feb 14, 2001 | Issued |
Array
(
[id] => 6880467
[patent_doc_number] => 20010031754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-18
[patent_title] => 'Method for treating ocular pain'
[patent_app_type] => new
[patent_app_number] => 09/783160
[patent_app_country] => US
[patent_app_date] => 2001-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2818
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20010031754.pdf
[firstpage_image] =>[orig_patent_app_number] => 09783160
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/783160 | Method for treating ocular pain | Feb 13, 2001 | Issued |
Array
(
[id] => 4333620
[patent_doc_number] => 06333056
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Herbal-based pharmaceutical formulations'
[patent_app_type] => 1
[patent_app_number] => 9/781547
[patent_app_country] => US
[patent_app_date] => 2001-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3083
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333056.pdf
[firstpage_image] =>[orig_patent_app_number] => 781547
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/781547 | Herbal-based pharmaceutical formulations | Feb 12, 2001 | Issued |